Thus, HFE hemochromatosis patients (61) and Hfe−/− mice (62) express inappropriately low hepcidin levels and exhibit blunted hepcidin responses to iron intake (8, 63) due to defective BMP/SMAD signaling (64, 65). This evidence concerns the gene HFE and hemochromatosis type 1.